About Neocannbio
Neocannbio is a company based in Seoul (South Korea) founded in 2021.. Neocannbio has raised $10.9 million across 2 funding rounds from investors including KT&G, Medytox and QUAD Investment Management. Neocannbio operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Neocannbio Co., Ltd.
-
Annual Revenue
$81.82 K (USD)372as on Dec 31, 2022
-
Net Profit
$-209.55 K (USD)-335as on Dec 31, 2022
-
EBITDA
$-209.55 K (USD)-335as on Dec 31, 2022
-
Total Equity Funding
$10.9 M (USD)
in 2 rounds
-
Latest Funding Round
$7.47 M (USD), Series B
Sep 26, 2023
-
Investors
KT&G
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neocannbio
Neocannbio has successfully raised a total of $10.9M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $7.47 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $7.5M
-
First Round
First Round
(26 Jul 2022)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series B - Neocannbio | Valuation | QUAD , Bilanx | |
| Jul, 2022 | Amount | Series A - Neocannbio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neocannbio
Neocannbio has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include KT&G, Medytox and QUAD Investment Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neocannbio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neocannbio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neocannbio Comparisons
Competitors of Neocannbio
Neocannbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| domain | founded_year | HQ Location |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| domain | founded_year | HQ Location |
Medical cannabis products are provided based on GMP processes.
|
|
| domain | founded_year | HQ Location |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| domain | founded_year | HQ Location |
Manufacturer of medicinal cannabis for therapeutic use
|
|
| domain | founded_year | HQ Location |
Developer of medical cannabis products
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neocannbio
Frequently Asked Questions about Neocannbio
When was Neocannbio founded?
Neocannbio was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Neocannbio located?
Neocannbio is headquartered in Seoul, South Korea.
Who is the current CEO of Neocannbio?
Jungyeob Ham is the current CEO of Neocannbio.
Is Neocannbio a funded company?
Neocannbio is a funded company, having raised a total of $10.9M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.43M, raised on Jul 26, 2022.
What is the annual revenue of Neocannbio?
Annual revenue of Neocannbio is $81.82K as on Dec 31, 2022.
What does Neocannbio do?
Neocannbio was founded in 2021 in Seoul, South Korea, within the biotechnology sector focused on cannabinoids. Cannabinoid-based drugs are developed using intelligent delivery systems and synergistic effects to enhance efficacy. A comprehensive cannabinoid library is built from hemp to support efficacy discoveries, assay services, and raw material production. Core technologies encompass microwave processing for high-purity CBD and metabolic engineering for scalable manufacturing.
Who are the top competitors of Neocannbio?
Neocannbio's top competitors include Avicanna, ZYUS Life Sciences and IMCannabis.
Who are Neocannbio's investors?
Neocannbio has 9 investors. Key investors include KT&G, Medytox, QUAD Investment Management, Bilanx, and Donghoon Investment.